Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PHARMACIES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 487 records · Page 27Linked to original sources

Comparison of adverse drug reactions detected by pharmacy and medical records departments.

Adverse drug reactions (ADRs) detected by the pharmacy and medical records departments of a multispecialty teaching hospital were studied. The charts of all adult patients who were identified by the pharmacy or medical records departments as having had an ADR and who were discharged from the hospital between July and September 1990 were reviewed. Data on patient demographics and the characteristics of the ADRs were collected, and the causality and severity of each ADR were assessed by two pharmacists and one physician. A total of 110 charts representing 117 ADRs were reviewed. Twenty-five (21%) of the ADRs were identified by the pharmacy department and 101 (86%) by the medical records department; 9 (8%) were reported by both departments. The pharmacy and medical records groups of patients were demographically similar, except that the percentage of patients admitted through the emergency room was significantly smaller for the pharmacy department group. ADRs identified by the pharmacy were most commonly cutaneous, and those identified by medical records were most commonly neurologic. For the pharmacy department, hypersensitivity reactions accounted for the largest number of ADRs, while for medical records the largest number involved abnormal laboratory test values. Anti-infectives were involved in two thirds of the pharmacy-identified ADRs, compared with only a fifth of the ADRs identified by medical records. Mean causality and severity scores did not differ significantly between the groups. The medical records department identified four times as many ADRs as the pharmacy department. Observed differences in the number and types of reactions, manifestations, patient locations, and suspected drugs probably reflect the different surveillance methods and ADR definitions used by the two departments.

Adult↗

Justifying and implementing an ophthalmic pharmacy practice.

The justification for and implementation of an ophthalmic care satellite pharmacy at the eye center of a university hospital are described. A pharmacy dedicated to ophthalmic care was developed in conjunction with a new eye care center. The eye center pharmacy staff, in consultation with other members of the pharmacy department, determined the services to be provided: preparing pharmaceuticals for operating room and clinic use, performing medication evaluations for all patients undergoing surgery, taking and documenting medication histories, providing distributive services, counseling surgical patients about their prescriptions and the care of their eyes after surgery, and checking on patients after discharge. Services were implemented after feedback was received from ophthalmology department physicians and from eye care pharmacies at other institutions. Before working in the eye center pharmacy, pharmacists received inservice instruction. To assist in its medication evaluation and counseling efforts, the pharmacy introduced a medical information form, which is used for both surgical and clinic patients. An adverse drug reaction-reporting program was also introduced. Establishment of a satellite pharmacy specializing in ophthalmic care resulted in improved outpatient and surgical pharmacy services and better provision of information on ophthalmic pharmaceuticals.

Humans↗

Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.

BACKGROUND: The aim of the study was to provide a critical and comprehensive overview of the published peer-reviewed evidence relating to community pharmacy-based activity in the reduction of risk behaviours and risk factors for coronary heart disease (CHD). METHOD: Electronic databases were searched from 1 January 1990 to 1 February 2001. Hand searches for the same period were undertaken of specific journals and proceedings of peer-reviewed conference abstracts. Data abstracted from publications included: participants/setting; study designs intervention including training); outcome measures; key findings. RESULTS: Four randomized controlled trials (RCTs) were identified, two in smoking cessation and two in lipid management. All met review criteria and were included. Two (RCTs) involving 976 subjects and three non-randomized experimental studies were identified that evaluated the effectiveness of community pharmacy advice in smoking cessation. Two controlled trials and one before-and-after study investigated the effect of training on pharmacists' smoking cessation advice. One attitudinal survey collected data on reactive and proactive smoking cessation advice-giving by community pharmacists. Two RCTs involving 642 subjects, and two observational studies were identified for community pharmacy-based lipid management. The published studies provided evidence of clinical and cost-effectiveness of community pharmacy services from UK RCTs in smoking cessation, and from US and Canadian RCTs in lipid management in the prevention of heart disease. Although the role of the community pharmacy in disease detection and case finding has been widely discussed, only a small number of studies was found. The findings indicated that further investigation is warranted in these areas. CONCLUSION: The peer-reviewed literature demonstrates the contribution of community pharmacy-based services to the reduction of risk behaviours and risk factors for CHD. The evidence supports the wider provision of smoking cessation and lipid management through community pharmacies. Health commissioners and planners can use the findings of this review to incorporate community pharmacy based health development activities into local health services. Further research is needed into the contribution of community pharmacy to disease detection and case finding as part of local public health strategies.

Community Pharmacy Services↗

White coat effect and white coat hypertension in community pharmacy practice.

OBJECTIVE: The aim of the present study was to investigate whether a white coat effect (WCE) can be observed and quantified in community pharmacy practice. METHODS: In five community pharmacies of Basel, Switzerland, clients asking for blood pressure (BP) measurement were recruited to participate in a free of charge study. Blood pressure was measured in four different settings: pharmacy (using mercury sphygmomanometers), outpatient clinic (measurement by a nurse using mercury sphygmomanometers), self-measurement at home (using automated wrist devices) and daytime ambulatory BP (ABP) monitoring (using SpaceLabs 90207 monitors). WCE was defined as the difference between pharmacy or outpatient and daytime ABP. RESULTS: A total of 50 subjects completed all measurements (42% male, mean age 53.7 years+/-14.0). Blood pressure values of the different settings: (means in mmHg+/-SD, systolic; diastolic): pharmacy BP 129+/-19; 82+/-10, outpatient clinic BP 127+/-15; 82+/-10, home BP 119+/-15; 73+/-9, daytime ABP 124+/-10; 79+/-8. Pharmacy BP was significantly higher (P=0.03 systolic; P=0.02 diastolic) compared with daytime ABP and differences among subjects with antihypertensive medication (n=22) were even more significant (P<0.01). Individual differences were found between pharmacy BP and daytime ABP: +4.6+/-14.8; +2.9+/-8.3. Outpatient BP was significantly higher compared with daytime ABP in diastolic (P=0.04) but not in systolic values. Individual differences between outpatient BP and daytime ABP were +2.5+/-13.1; +2.8+/-9.2. 'Clinically important WCE' (>or=20 mmHg systolic or >or=10 mmHg diastolic) was observed in 24% of all subjects in the pharmacy and in 20% in the outpatient clinic. CONCLUSIONS: Our findings show that WCE and white coat hypertension exist in community pharmacy practice and are similar to the effects in an outpatient clinic.

Adult↗

Pharmacy clerks' prescribing practices for STD patients in Porto Alegre, Brazil: missed opportunities for improving STD control.

STDs are a significant public health problem in Brazil. A primary control strategy is the immediate treatment of symptomatic individuals. When services are unavailable, STD patients seek care in alternative settings. Probably the most frequently used settings are commercial pharmacies, where pharmacy clerks provide treatment, although Brazilian law prohibits selling antibiotics without prescription. Our objective was to evaluate prescribing practices by pharmacy clerks for STDs. We performed a cross-sectional study. Trained medical students visited 62 pharmacies in the city of Porto Alegre during March 2002. These were randomly chosen from a list of 863 registered pharmacies. The students presented to the pharmacy complaining of dysuria and urethral discharge. After obtaining a prescription, or not, they asked for additional instructions to be followed. Immediately after leaving the premises, the instructions were anonymously recorded. Of the 62 pharmacies visited, a clerk in 56 (90.3%, 95% confidence interval [CI]: 80.1%-96.4%) provided a prescription. Most frequently prescribed drugs were ampicillin with probenecide (29/51.8%) and rosoxacin (11/19.6%). Ministry of Health-recommended treatment was not suggested by any of the clerks. Forty-six additional recommendations were given. The use of condoms was the most frequent additional advice (42/46). Prescribing by pharmacy clerks is very prevalent in Porto Alegre. This may represent a lost opportunity for more comprehensive prevention effort (counselling, partner management, and diagnosing other STDs). Additionally, the most frequently prescribed drugs are not recommended by international or national health authorities for treatment of STDs, and none of these drugs covers chlamydia. We conclude that pharmacy clerks are a potentially important source of STD treatment and control but that their practices are in need of vast improvement.

Anti-Bacterial Agents↗

Limited access to syringes for injection drug users in pharmacies in Denver, Colorado.

OBJECTIVE: To determine the availability of syringes for injection drug users (IDUs) from pharmacies in Denver. DESIGN: Single-group, uncontrolled, noncomparative study. SETTING: Denver, Colorado. PATIENTS OR OTHER PARTICIPANTS: 23 randomly selected pharmacies in the Denver metropolitan area and 3 additional pharmacies located near drug-buying locations. INTERVENTION: Attempt by eight trained IDU "research assistants" to purchase packages of 10 U-100 insulin syringes without a prescription from pharmacies. MAIN OUTCOME MEASURES: Successful purchase of syringes; reasons for refusal. RESULTS: Of 26 pharmacies, 4 reported not stocking syringes, 3 did not sell syringes to any research assistants, 10 sold to some research assistants but not to others, and 9 sold to all research assistants. Of 206 purchase attempts, 54% were successful. In 37.9% of 95 refusals, the pharmacist reported that syringes were not sold at the store, and in 28.4% the pharmacist refused to sell because the research assistant did not produce diabetic identification or answer insulin-related questions. No differences in pharmacy response were found with respect to the racial or ethnic characteristics of the research assistant. Price varied substantially within and among stores. No pharmacies that sold syringes to research assistants were open 24 hours per day. CONCLUSION: While IDUs who live near a pharmacy that regularly sells syringes and IDUs with a convincing diabetes story may have adequate access to syringes, others face inconsistent availability. Price fluctuations and limited hours of those pharmacies that sell syringes may be additional barriers to access to sterile syringes for IDUs in Denver.

Colorado↗

Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.

OBJECTIVE: To describe the nature and extent of patient counseling in community pharmacies and determine whether current counseling practices are influenced by pharmacist and pharmacy characteristics and variations in state regulation of patient counseling. DESIGN: Observational, cross-sectional study. SETTING: 306 community pharmacies in eight states. PARTICIPANTS: Trained shoppers (acting as patients). INTERVENTIONS: Three new prescriptions were presented in each pharmacy, and regression techniques were used to analyze the effects of pharmacist age, pharmacy type, and busyness; whether written information was provided; and "intensity" of a state's patient counseling regulation as measured by its scope, stringency, and duration. MAIN OUTCOME MEASURES: Whether any or all of these events occurred: pharmacist talked with shopper, oral drug information was given, oral risk information was given, and/or questions were asked to assess shopper understanding; number of informational items mentioned (range 0-7) was also recorded. RESULTS: About 63% of the shoppers were given oral drug information (mean = 2.3 items). Shoppers with a younger responsible pharmacist were more likely than other shoppers to receive risk information, a higher number of informational items, and assessment of understanding. While pharmacy type was unrelated to counseling, busyness reduced the odds of any pharmacist talk, oral information-giving, and assessment of understanding. Counseling practices varied significantly according to the intensity of a state's counseling regulation, with frequency of any information provision climbing from 40% to 94% as states' counseling regulations increased in intensity. More intensive regulations also increased the likelihood of any pharmacist talk, any provision of risk information, any assessment of shopper understanding, and amount of oral information given. CONCLUSION: Counseling varied significantly according to intensity of state regulation, pharmacy busyness, and age of responsible pharmacist. These results present important challenges to state boards of pharmacy, pharmacy associations, managers, and individual practitioners who are in a position to improve this important element of patient care.

Age Factors↗

Retrospective financial analysis of wellness center from an independent community pharmacy perspective.

OBJECTIVE: To determine the net financial gain or loss from health screening services provided to patients at an independent community pharmacy-based wellness center. DESIGN: Retrospective review of pharmacy wellness center records over a 24-month period. SETTING: A wellness center at one independent community pharmacy. PARTICIPANTS: Patients receiving one or more of nine different services (blood pressure [BP], blood glucose, body fat [BF], glycosylated hemoglobin [A1C], bone density [BD], total cholesterol/blood glucose, total lipid panel [TLP], total cholesterol/high-density lipoprotein, alanine aminotransferase) during a 2-year period. INTERVENTIONS: The services were performed and results recorded by a resident or staff pharmacist. MAIN OUTCOME MEASURES: Using a pharmacy perspective, net financial gains or losses were calculated for each of the individual services, for all of the services performed using the Cholestech LDX Analyzer, and for the wellness center as a whole. Sensitivity analyses were based upon a pharmacist, a pharmacy resident, or both a pharmacist and pharmacy resident each providing half of the total number of services over the 2-year period. RESULTS: A total of 1,181 pharmacy records for the selected services were reviewed for the specified time period. A net financial gain for the wellness center was achieved when the services were performed by a pharmacist, a pharmacy resident, or a pharmacist/pharmacy resident combination, respectively. Three of the individual services (BG, BF and TLP) and assays performed using the Cholestech LDX Analyzer had a net financial gain for each sensitivity analysis. Two of the services (BP and AIC) had a net financial gain only when a resident provided the service. One of the services (BD) had a net financial loss for all of analyses. CONCLUSION: Revenues for these services exceeded their costs from the wellness center perspective when they were performed by a pharmacist, a pharmacy resident, or a pharmacist/pharmacy resident combination.

Community Pharmacy Services↗

Nonprescription drug-related problems and pharmacy interventions.

OBJECTIVE: To document the number and types of drug-related problems (DRPs) identified in customers purchasing nonprescription products in Swedish pharmacies; describe the distribution of DRPs by customer's gender, age, underlying ailment, and class of drug; determine whether problems are identified to the same extent in pharmacies with staffed nonprescription self-service departments as in pharmacies with over-the-counter sales; and document the number and types of pharmacy interventions to prevent or resolve DRPs, including reasons for drug switches and referrals to physicians. METHODS: A computerized instrument for documentation of DRPs and pharmacy interventions was developed. The study was conducted in 45 volunteer pharmacies in Sweden during 10 weeks in late 1999. RESULTS: A total of 1,425 problems and 2,040 interventions were recorded by 308 pharmacy practitioners. Relatively fewer DRPs were documented in pharmacies with self-service departments. The most common DRPs were uncertainty about the indication for the drug (33.5%) and therapy failure (19.5%). Dyspepsia was the most frequently specified symptom (11.4%). Consumers of dermatologic products had significantly higher rates of problems than expected in relation to sales volume. The most common ways of responding to a problem were with consumer drug counseling (61.1%), switching of drugs (43.9%), and referral to a physician (27.5%). CONCLUSIONS: The study has demonstrated a need for more professional attention and intervention by pharmacy staff to prevent and rectify DRPs in nonprescription consumers. It seems especially important to make sure that consumers receive the appropriate drugs for their current ailments.

Adolescent↗

Pharmacy access to emergency contraception in California.

CONTEXT: California is one of eight states that allow a woman to obtain emergency contraceptives from a pharmacy without a physician prescription. Because many women do not know about emergency contraception or direct pharmacy access, it is important to understand barriers to getting the method and women's reasons for choosing the pharmacy option. METHODS: In a 2004 survey at 25 predominantly independent pharmacies across California that offered pharmacy access, 426 women completed questionnaires after obtaining emergency contraceptives. They were asked about their reasons for seeking the method, the time of unprotected intercourse, barriers to access, how they learned about pharmacy access and their reasons for choosing it. Chi-square tests and analysis of variance were used to assess differences between subgroups. RESULTS: Eighty-six percent of women wanted emergency contraceptives for immediate use, and women obtained the method an average of 36 hours after unprotected intercourse. Those younger than 16, those who had had unprotected sex on the weekend and those who were embarrassed to ask for the method or who did not know about it all took a longer time to get the medication than did their respective comparison groups. Women who chose pharmacy access did so because they thought it was faster (54%) and more convenient (47%) than seeking a physician prescription. The majority reported that talking to a pharmacist was very helpful (84%) and that it was very important to be able to get the method directly from a pharmacy (81%). CONCLUSIONS: Increasing women's knowledge about emergency contraception and its availability directly from pharmacies has the potential to improve the effectiveness of this contraceptive method by reducing the time interval between unprotected intercourse and initiation of treatment.

Adolescent↗

A feasibility study for recording of dispensing errors and near misses' in four UK primary care pharmacies.

Medication errors can occur at the prescribing, transcription, dispensing and administration stage of drug therapy. However, publication of the Organisation with a Memory (OWAM) by the Department of Health in the UK has raised awareness of the need for pharmacies to collect information about dispensing errors and near misses, which occur within an organisation. Such information provides valuable insights into the vulnerabilities of dispensing procedures and identifies areas for improvement in dispensing systems The main aim of this study was to investigate the feasibility of a self-reporting system for dispensing errors and near misses in primary care (community) pharmacies. It was also to identify the types of errors or near misses commonly encountered in community pharmacies. A data collection form was designed and modified for use after a pilot study. Four community pharmacies volunteered to participate in this feasibility study. The data collection was conducted in two phases each of 4 weeks' duration. Any dispensing errors and near misses that occurred during the study periods were recorded by the pharmacy staff in a standard data collection form. A focus group discussion was held with the dispensing staff of participating pharmacies to identify and evaluate the feasibility of the reporting system. Out of a total of 51 357 items dispensed during the two phases of the study, 39 dispensing errors (0.08%) and 247 near misses (0.48%) were detected. The results show that near misses occurred six times more often than dispensing errors, indicating the importance of final checking in pharmacies. The most common types of dispensing errors or near misses appeared to be incorrect strength of medication, followed by incorrect drug, incorrect quantity, incorrect dosage form and incorrect label. Feedback during the focus group discussion indicated that the outcome of the self-reporting scheme was more important than the incidence of errors or near misses. Participating pharmacies also agreed that the self-reporting scheme used was feasible and they would continue using the scheme although some incentives would be helpful. The quantitative results of this study and the qualitative feedback from the participating pharmacies indicate that the self-reporting scheme used is practical and feasible.

Data Collection↗

Pharmacy costs and glycemic control in the Department of Veterans Affairs.

OBJECTIVE: To determine pharmacy costs for glycemic treatment and its relationship to glycemic control in the Department of Veterans Affairs (VA) between 1994 and 2000. RESEARCH DESIGN AND METHODS: Patients with diabetes in the VA in FY1994, FY1996, FY1998, and FY2000 were identified using an ambulatory care pharmacy-derived database. Total drug acquisition costs, as well as expenditures for insulin, oral glycemic control agents, and self-blood glucose monitoring strips, were determined for these veterans. HbA(1c) levels for the corresponding time periods were also obtained. Pharmacy costs (medications and monitoring) were examined by glycemic control treatment type. RESULTS: In FY2000, 18% (n = 535,016) of all VA pharmacy patients were identified as having diabetes, and they received 30% of all pharmacy prescriptions. Overall, 23% of pharmacy expenditures for these patients were related to glycemic control medications and monitoring supplies. Annual pharmacy costs increased from FY1994 to FY2000. The greatest change was the higher expenditure for monitoring supplies through FY1998, which then decreased in FY2000. Increased pharmacy costs were associated with improved glycemic control. In FY2000, the mean last HbA(1c) level (n = 446,384) fell to 7.6% from 7.8% in FY1998 (n = 204,136) and 8.4% in 1996 (n = 53,348). CONCLUSIONS: Diabetes was associated with high pharmacy costs. Increasing medication expenditures were associated with improved HbA(1c) levels at the aggregated national level. Policies concerning dispensing monitoring supplies and several diabetes quality improvement projects were initiated during this interval. Future challenges include initiatives to further optimize care while controlling costs.

Blood Chemical Analysis↗

A prescription for better pharmacy computerization.

The net effect of these features in an integrated system is that the pharmacist spends time more productively managing patient drug therapy, not the computer system. The patient's location and demographics, once entered, are immediately available in a clinically useful form. Information about medications, the patient's responses to them and all other clinical parameters is available in the pharmacy without leaving the pharmacy application, making the pharmacist more effective and efficient. Physicians' orders are qualified by the system as they are entered, minimizing the number of nonproductive encounters between the pharmacist and the physician. Medication orders arrive at the pharmacy in a more timely manner and with fewer problems. The pharmacy can, in turn, be more responsive, helping the patient receive medication that is timely, accurate and clinically appropriate. These benefits arise primarily as a by-product of the pharmacy being integrated into an information system environment in which data is easily and directly accessed and shared. The more closely the pharmacy and its information requirements are examined, the more important the integration component appears. Many of the above benefits are not achievable with a dedicated stand-alone pharmacy computer system; some are achievable with an interface to a stand-alone nursing-station based HIS. In the pharmacy, is to increase and flourish in its role as an important and integral part of the healthcare delivery team, then access by the pharmacist to all patient information, and access by other providers to information contributed by the pharmacy is a necessary requisite. Improvement inpatient care can be the only result of such enhanced interchange.

Hospital Information Systems↗

Faculty evaluations of texts used to teach pharmacy financial management.

The objectives of this survey were to determine which texts were used to teach financial management to pharmacy students, to gather instructors' evaluations of the texts, and to determine which financial management topics were most often covered in pharmacy courses. Data for the study were collected via a mail questionnaire survey sent to a selected pharmacy administration faculty member at each school of pharmacy in the United States and Puerto Rico. A 90 percent response rate was achieved. The results indicated that the most frequently used texts were Effective Pharmacy Management and Principles and Methods of Pharmacy Management. Evaluations of these texts indicated that instructors who used them were, for the most part, satisfied with them. Major points of dissatisfaction were the number and types of problems included. Pharmacy courses covered a wide range of financial management and managerial accounting topics. Bookkeeping topics were much less likely to be covered. None of the available pharmacy texts covered all topics which are usually taught in courses of pharmacy financial management.

Books↗

[Opinions and attitudes of patients visiting pharmacies].

The paper is devoted to the problems concerning the opinions and attitudes of customers of pharmacies, i.e. their opinions on and attitudes to the question of information needs and satisfaction with information and services provided in pharmacies in the Czech Republic. The article presents the results of a questionnaire survey answering the following questions: why the respondents come to pharmacies and what the reason of the present visit is, whom they prefer as the dispenser of the drug and why, how often they went to a pharmacy in the recent period, from where they get information concerning drugs, whether it is advantageous for them to obtain information in a pharmacy and what information they received during the present visit, who provided the information or advice, how many pieces of information they got and how they are satisfied with them, whether they required information in a pharmacy, or whether they came to a pharmacy for this purpose, why the respondents have purposefully selected a particular pharmacy, whether they take drugs daily and which ones, what their opinion on the amount the supplementary payment is, what OTC drugs they buy, what drugs they prefer, whether they concentrate on a certain preparation, or possibly which one, what is their opinion about the scale of the assortment of OTC drugs, whether they use homeopathic medicines, and what they miss in pharmacies.

Adult↗

[Pharmacy in Canton Vaud during the period of radical domination: 1845-1945].

Between 1845 and 1945, major changes took place both in society and in pharmacy. These two dates represent important phases of mutation for the pharmacy profession. In 1845, university studies were about to become compulsory. Towards 1945, the prodigious development of patent medicines had been disconcerting the pharmaceutical community. In this time period, pharmacy had taken a more modern face: School of pharmacy was founded (1873), professional associations were being formed up and the first hospital pharmacy was established in 1882. Politically, this period of time was marked by the hegemony of the Radical party. Society was at a turning point. The expanding railway network and the development of industry in certain regions were influencing the implantation of pharmacies and their unequal distribution in the Canton. Based on archive documents, the different aspects of pharmacy in Canton Vaud at this epoch have been examined and analyzed. In particular, evolution of legislation and of professional training have been studied with reference to previous time periods or to the situation in other cantons of countries.The creation and development of professional associations has also been treated. One chapter is devoted to a brief description of the careers of more than one hundred pharmacists. The activities of the Cantonal Hospital pharmacy are also outlined, as well as the increase in the number of pharmacies within the context of economical growth in different regions of the Canton. Tables and addenda are used to support the discussions in the different chapters. This study should allow the present generation of pharmacists to have a better knowledge of the history of their profession and thus understand its evolution.

History of Pharmacy↗

Justification for a pediatric satellite pharmacy at a tertiary-care institution.

The justification for a pediatric satellite pharmacy is described. Of the 742 inpatient beds in a tertiary-care medical center, 150 are dedicated to pediatric patients. The pharmacy department provides services to both adult and pediatric patients from a central pharmacy. However, unit dose drug distribution services are not provided to the nurseries. Furthermore, the department lacks a core of pharmacists specializing in pediatric practice. As a result, the ability of the pharmacy to support pediatric drug use has been compromised, and medication errors and infection control problems have occurred that can be attributed to this situation. A pediatric satellite pharmacy was proposed to improve the quality of pediatric care. Service objectives were established, and benefits were identified. A financial analysis was included in the proposal that documented a total gain attributable to a pediatric satellite pharmacy of approximately $285,000 over five years. The satellite pharmacy was approved by hospital administration. The pharmacy department's quality assurance committee will monitor the satellite's impact. The justification for a proposed pediatric satellite pharmacy included indications that the satellite could correct medication-related problems and improve pediatric care and that implementation would have a positive effect on finances.

Child, Preschool↗

Surgical satellite pharmacies in institutions with anesthesiology training programs for physicians.

The results of a survey on the use of surgical satellite pharmacies in hospitals with anesthesiology training programs are reported. In June 1990 a questionnaire was mailed to 158 directors of anesthesiology training programs for physicians. The questionnaire solicited information on the presence of surgical satellite pharmacies in the training hospitals and the nature of the services provided, including accounting for controlled substances. Responses were received from 102 program directors and their designees, for a 65% response rate. Some respondents returned questionnaires completed by affiliated hospitals; a total of 137 responses were accumulated. Surgical satellite pharmacies were present in 46 (34%) of the 137 hospitals. Of those 46 satellite pharmacies, only 14 dispensed all controlled substances to anesthetic-administration areas. Most of the satellite pharmacies provided services at least eight hours per day. All 46 pharmacies dispensed controlled substances, 31 provided i.v. admixtures, and 12 dispensed all i.v. solutions. Accountability for controlled drugs was provided through a daily inventory count (45 satellite pharmacies), daily comparison of agents received and returned (36), review of the anesthesia record (31), random audits of individual providers (18), or quantitative or qualitative analysis of residual drugs (16). Accountability was considerably better in hospitals with surgical satellite pharmacies than in hospitals without them. Surgical satellite pharmacies provided increased accountability for controlled substances in institutions with anesthesiology training programs but did not use all the available methods for preventing drug diversion.

Anesthesiology↗